Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Yinghui  [Clear All Filters]
2024
Li Y, Liu X, Sun X, Li H, Wang S, Tian W, Xiang C, Zhang X, Zheng J, Wang H, et al. Gut dysbiosis impairs intestinal renewal and lipid absorption in Scarb2 deficiency-associated neurodegeneration. Protein Cell. 2024.
Han X, Qu L, Yu M, Ye L, Shi L, Ye G, Yang J, Wang Y, Fan H, Wang Y, et al. Thiamine-modified metabolic reprogramming of human pluripotent stem cell-derived cardiomyocyte under space microgravity. Signal Transduct Target Ther. 2024;9(1):86.
2023
Li Y, He M, Zhang W, Liu W, Xu H, Yang M, Zhang H, Liang H, Li W, Wu Z, et al. Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche. Nat Commun. 2023;14(1):2207.
2022
Lim SKiat, Peng CChen, Low S, Vijay V, Budiman A, Phang BHooi, Lim JQuan, Jeyasekharan AD, Lim SThye, Ong CKiat, et al. Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL. Leukemia. 2022.
2021
Li Y, Li Y, Yin J, Wang C, Yang M, Gu J, He M, Xu H, Fu W, Zhang W, et al. A mitophagy inhibitor targeting p62 attenuates the leukemia-initiation potential of acute myeloid leukemia cells. Cancer Lett. 2021.
2020
Li Y, Gu J, Ding Y, Gao H, Li Y, Sun Y, He M, Zhang W, Yin J, Bai C, et al. A small molecule compound IX inhibits telomere and attenuates oncogenesis of drug-resistant leukemia cells. FASEB J. 2020.